Hidehito Horinouchi

Hidehito Horinouchi

UNVERIFIED PROFILE

Are you Hidehito Horinouchi?   Register this Author

Register author
Hidehito Horinouchi

Hidehito Horinouchi

Publications by authors named "Hidehito Horinouchi"

Are you Hidehito Horinouchi?   Register this Author

75Publications

1510Reads

43Profile Views

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR-TKI failure.

Thorac Cancer 2020 Feb 20. Epub 2020 Feb 20.

Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.13360DOI Listing
February 2020

Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study.

Eur J Cancer 2019 May 13;113:78-86. Epub 2019 Apr 13.

Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.03.012DOI Listing
May 2019

[II. Treatment Strategy for Locally Advanced Non-Small Cell Lung Cancer - Perspective of Medical Oncologist].

Gan To Kagaku Ryoho 2018 08;45(8):1152-1154

Dept. of Thoracic Oncology, National Cancer Center Hospital.

View Article

Download full-text PDF

Source
August 2018

KEYNOTE-010: flash of a supernova (immune-checkpoint inhibitors) in second-line non-small cell lung cancer.

J Thorac Dis 2017 Nov;9(11):4187-4190

Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.10.135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720970PMC
November 2017

Efficacy and safety of osimertinib in a Japanese compassionate use program.

Jpn J Clin Oncol 2017 Jul;47(7):625-629

Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx050DOI Listing
July 2017

PD-L1 expression in neuroendocrine tumors of the lung.

Lung Cancer 2017 06 24;108:115-120. Epub 2017 Mar 24.

Department of Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.006DOI Listing
June 2017

Role of multimodality therapy in cIIIA-N2 non-small cell lung cancer: perspective.

Jpn J Clin Oncol 2016 Dec 4;46(12):1174-1178. Epub 2016 Oct 4.

Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyw131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144660PMC
December 2016

The prospect of patritumab for treating non-small cell lung cancer.

Expert Opin Biol Ther 2016 12 3;16(12):1549-1555. Epub 2016 Nov 3.

a Department of Thoracic Oncology , National Cancer Center Hospital , Tokyo , Japan.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14712598.2016.1
Publisher Site
http://dx.doi.org/10.1080/14712598.2016.1249846DOI Listing
December 2016

Anti-vascular endothelial growth factor therapies at the crossroads: linifanib for non-small cell lung cancer.

Transl Lung Cancer Res 2016 Feb;5(1):78-81

1 Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan ; 2 Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.06.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758963PMC
February 2016

Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.

Int J Radiat Oncol Biol Phys 2016 Jan 26;94(1):155-162. Epub 2015 Sep 26.

Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.09.026DOI Listing
January 2016

Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.

Invest New Drugs 2015 Jun 18;33(3):632-40. Epub 2015 Mar 18.

Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-015-0227-5
Publisher Site
http://dx.doi.org/10.1007/s10637-015-0227-5DOI Listing
June 2015

Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer.

Lung Cancer 2015 Jun 19;88(3):275-81. Epub 2015 Mar 19.

Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.03.010DOI Listing
June 2015

Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.

Lung Cancer 2015 May 10;88(2):154-9. Epub 2015 Mar 10.

Division of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.03.003DOI Listing
May 2015

Secondary osteosarcoma developing 10 years after chemoradiotherapy for non-small-cell lung cancer.

Jpn J Clin Oncol 2014 Feb 13;44(2):191-4. Epub 2013 Dec 13.

*Division of Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 1040045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt192DOI Listing
February 2014

Short hydration in chemotherapy containing cisplatin (≥75 mg/m2) for patients with lung cancer: a prospective study.

Jpn J Clin Oncol 2013 Nov 4;43(11):1105-9. Epub 2013 Sep 4.

*Division of Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt122DOI Listing
November 2013

Successful EGFR-TKI rechallenge of leptomeningeal carcinomatosis after gefitinib-induced interstitial lung disease.

Jpn J Clin Oncol 2013 Apr 13;43(4):422-5. Epub 2013 Feb 13.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyt012DOI Listing
April 2013

Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.

Cancer Sci 2013 Jan 8;104(1):93-7. Epub 2012 Nov 8.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12028DOI Listing
January 2013

Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factor.

Cancer Sci 2012 Apr 20;103(4):756-9. Epub 2012 Feb 20.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2012.02217.xDOI Listing
April 2012

Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancer.

Clin Lung Cancer 2012 Jan 3;13(1):39-43. Epub 2011 Sep 3.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152573041100156
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2011.06.008DOI Listing
January 2012

Organising pneumonia after near-drowning.

BMJ Case Rep 2009 11;2009. Epub 2009 Jun 11.

St. Luke's International Hospital, Division of Respiratory Medicine, 9-1, Akashi-cho, Tokyo, 104-8560, Japan.

View Article

Download full-text PDF

Source
http://casereports.bmj.com/cgi/doi/10.1136/bcr.02.2009.1557
Publisher Site
http://dx.doi.org/10.1136/bcr.02.2009.1557DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029917PMC
November 2011

[The cutting-edge of medicine; Ethnic and gender differences in lung cancer].

Nihon Naika Gakkai Zasshi 2011 Oct;100(10):3064-71

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/naika.100.3064DOI Listing
October 2011

Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.

Jpn J Clin Oncol 2011 Aug 7;41(8):1013-6. Epub 2011 Jul 7.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyr089DOI Listing
August 2011

Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lung.

Jpn J Clin Oncol 2011 Jul 2;41(7):897-901. Epub 2011 Jun 2.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyr065DOI Listing
July 2011

Innovator and generic cisplatin formulations: comparison of renal toxicity.

Cancer Sci 2011 Jan 5;102(1):162-5. Epub 2010 Nov 5.

Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2010.01764.xDOI Listing
January 2011

[Two cases of invasive pulmonary aspergillosis mimicking pneumonia in lung cancer patients].

Nihon Kokyuki Gakkai Zasshi 2009 Sep;47(9):786-92

Division of Pulmonary Medicine, St. Luke's International Hospital.

View Article

Download full-text PDF

Source
September 2009

Gemcitabine plus UFT combination chemotherapy as second- or third-line therapy in non-small cell lung cancer: a pilot study.

J Med Invest 2008 Aug;55(3-4):260-6

Division of Pulmonary Medicine, St. Luke's International Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2152/jmi.55.260DOI Listing
August 2008

[Effects of the new clinical training system. 5. From the viewpoint of an intern].

Nihon Naika Gakkai Zasshi 2007 Dec;96(12):2715-21

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/naika.96.2715DOI Listing
December 2007